| Literature DB >> 34058569 |
Kai K Kummer1, Maximilian Zeidler1, Theodora Kalpachidou1, Michaela Kress2.
Abstract
The pleiotropic cytokine interleukin-6 (IL-6) is emerging as a molecule with both beneficial and destructive potentials. It can exert opposing actions triggering either neuron survival after injury or causing neurodegeneration and cell death in neurodegenerative or neuropathic disorders. Importantly, neurons respond differently to IL-6 and this critically depends on their environment and whether they are located in the peripheral or the central nervous system. In addition to its hub regulator role in inflammation, IL-6 is recently emerging as an important regulator of neuron function in health and disease, offering exciting possibilities for more mechanistic insight into the pathogenesis of mental, neurodegenerative and pain disorders and for developing novel therapies for diseases with neuroimmune and neurogenic pathogenic components.Entities:
Keywords: Brain disorders; Gp130; IL-6; Neuron development; Neuropathic pain; Regeneration
Mesh:
Substances:
Year: 2021 PMID: 34058569 DOI: 10.1016/j.cyto.2021.155582
Source DB: PubMed Journal: Cytokine ISSN: 1043-4666 Impact factor: 3.861